Proposed to raise capital 1 billion "betting" ginseng purple xin Pharmaceutical industry started directional additional

June 29 Suspension of the purple Xin Pharmaceutical industry today disclosed targeted additional plans.　　The company intends to publish not more than 90 million shares, raise funds 1 billion yuan for the series of ginseng products, will form 800 tons/year of ginseng deep processing capacity. The plan shows that the company this directional additional price is not lower than the pricing benchmark 20 trading day Stock Exchange 90%, that is 11.29 yuan/shares, the price of the last session of the pharmaceutical industry close (11.67 yuan/share) slightly lower.　　The company intends to invest the proceeds of investment in Ginseng products serialization project, in the main ginseng production areas in Jilin province Yanji, Dunhua, Tonghua, Panshi construction of four manufacturing and processing bases, engaged in deep processing and finishing, of which deep-processing products include raw ginseng, strong ginseng, molded red ginseng, finishing products including related proprietary Chinese medicine, ginseng enzyme drinks. Purple Xin Pharmaceutical said, the directional additional completion, the company will form 800 tons/year of ginseng deep processing capacity, enrich the product variety, optimize product structure and income structure, conducive to the overall upgrading of the company's core competitiveness, enhance profitability.